This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Arctic Pharma as, Spermatech as. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Steffi Lundvall: Innovator in Cancer Treatment
Introduction
Steffi Lundvall is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of medical research, particularly in the development of compounds that target lactate dehydrogenase A (LDHA). Her work is crucial in the fight against diseases such as cancer.
Latest Patents
Steffi Lundvall holds 1 patent for her invention related to LDHA activity inhibitors. The invention provides compounds of formula (I), including stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs. These compounds are designed for the treatment or prevention of diseases mediated by the activation of LDHA, making them particularly relevant in cancer therapy.
Career Highlights
Steffi is currently employed at Arctic Pharma AS, where she continues to innovate and develop new therapeutic solutions. Her expertise in biochemistry and pharmacology has positioned her as a key player in her field.
Collaborations
Throughout her career, Steffi has collaborated with notable colleagues, including Jo Klaveness and Bora Sieng. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Steffi Lundvall's work in developing LDHA activity inhibitors represents a significant advancement in cancer treatment. Her innovative spirit and dedication to research continue to inspire progress in the medical field.